8 [19] Y. Zeng and B. R. Cullen, “Eﬃcient processing of primary microRNA hairpins by Drosha requires ﬂanking nonstruc- tured RNA sequences,” The Journal of Biological Chemistry, vol. 280, no. 30, pp. 27595–27603, 2005. [20] J. Han, Y. Lee, K. H. Yeom et al., “Molecular basis for the recognition of primary microRNAs by the drosha-DGCR8 complex,” Cell, vol. 125, no. 5, pp. 887–901, 2006. [21] R. Yi, Y. Qin, I. G. Macara, and B. R. Cullen, “Exportin- 5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs,” Genes and Development, vol. 17, no. 24, pp. 3011–3016, 2003. [22] K. Okamura, J. W. Hagen, H. Duan, D. M. Tyler, and E. C. Lai, “The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila,” Cell, vol. 130, no. 1, pp. 89–100, 2007. [23] J. G. Ruby, C. H. Jan, and D. P. Bartel, “Intronic microRNA precursors that bypass Drosha processing,” Nature, vol. 448, no. 7149, pp. 83–86, 2007. [24] E. Berezikov, W. J. Chung, J. Willis, E. Cuppen, and E. C. Lai, “Mammalian Mirtron Genes,” Molecular Cell, vol. 28, no. 2, pp. 328–336, 2007. [25] V. N. Kim, J. Han, and M. C. Siomi, “Biogenesis of small RNAs in animals,” Nature Reviews Molecular Cell Biology, vol. 10, no. 2, pp. 126–139, 2009. [26] T. P. Chendrimada, R. I. Gregory, E. Kumaraswamy et al., “TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing,” Nature, vol. 436, no. 7051, pp. 740–744, 2005. [27] A. D. Haase, L. Jaskiewicz, H. Zhang et al., “TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing,” EMBO Reports, vol. 6, no. 10, pp. 961–967, 2005. [28] R. W. Carthew and E. J. Sontheimer, “Origins and Mecha- nisms of miRNAs and siRNAs,” Cell, vol. 136, no. 4, pp. 642– 655, 2009. [29] M. E. LLeonart, A. Artero-Castro, and H. Kondoh, “Senes- cence induction; a possible cancer therapy,” Molecular Can- cer, vol. 8, article 3, 2009. [30] M. Collado and M. Serrano, “Senescence in tumours: evidence from mice and humans,” Nature Reviews Cancer, vol. 10, no. 1, pp. 51–57, 2010. [31] M. Serrano, A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe, “Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16(INK4a),” Cell, vol. 88, no. 5, pp. 593–602, 1997. [32] J. Campisi and F. D’Adda Di Fagagna, “Cellular senescence: when bad things happen to good cells,” Nature Reviews Molecular Cell Biology, vol. 8, no. 9, pp. 729–740, 2007. [33] C. J. Sherr and F. McCormick, “The RB and p53 pathways in cancer,” Cancer Cell, vol. 2, no. 2, pp. 103–112, 2002. [34] C. L. Olsen, B. Gardie, P. Yaswen, and M. R. Stampfer, “Raf- 1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion,” Oncogene, vol. 21, no. 41, pp. 6328–6339, 2002. [35] M. Collado, J. Gil, A. Efeyan et al., “Tumour biology: senescence in premalignant tumours,” Nature, vol. 436, no. 7051, p. 642, 2005. [36] M. Braig and C. A. Schmitt, “Oncogene-induced senescence: putting the brakes on tumor development,” Cancer Research, vol. 66, no. 6, pp. 2881–2884, 2006. [37] J. Campisi, “Senescent cells, tumor suppression, and organ- ismal aging: good citizens, bad neighbors,” Cell, vol. 120, no. 4, pp. 513–522, 2005. Journal of Aging Research [38] J. C. Jeyapalan, M. Ferreira, J. M. Sedivy, and U. Herbig, “Accumulation of senescent cells in mitotic tissue of aging primates,” Mechanisms of Ageing and Development, vol. 128, no. 1, pp. 36–44, 2007. [39] P. Castro, D. Giri, D. Lamb, and M. Ittmann, “Cellular senes- cence in the pathogenesis of benign prostatic hyperplasia,” Prostate, vol. 55, no. 1, pp. 30–38, 2003. [40] G. T. Bommer, I. Gerin, Y. Feng et al., “p53-mediated activation of miRNA34 candidate tumor-suppressor genes,” Current Biology, vol. 17, no. 15, pp. 1298–1307, 2007. [41] T. C. Chang, E. A. Wentzel, O. A. Kent et al., “Transactivation of miR-34a by p53 broadly inﬂuences gene expression and promotes apoptosis,” Molecular Cell, vol. 26, no. 5, pp. 745– 752, 2007. [42] H. Tazawa, N. Tsuchiya, M. Izumiya, and H. Nakagama, “Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells,” Proceedings of the National Acad- emy of Sciences of the United States of America, vol. 104, no. 39, pp. 15472–15477, 2007. [43] M. Yamakuchi and C. J. Lowenstein, “MiR-34, SIRT1 and p53: the feedback loop,” Cell Cycle, vol. 8, no. 5, pp. 712–715, 2009. [44] N. R. Christoﬀersen, R. Shalgi, L. B. Frankel et al., “P53- independent upregulation of miR-34a during oncogene- induced senescence represses MYC,” Cell Death and Diﬀer- entiation, vol. 17, no. 2, pp. 236–245, 2010. [45] E. Langley, M. Pearson, M. Faretta et al., “Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence,” EMBO Journal, vol. 21, no. 10, pp. 2383–2396, 2002. [46] C. Welch, Y. Chen, and R. L. Stallings, “MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells,” Oncogene, vol. 26, no. 34, pp. 5017–5022, 2007. [47] I. Martinez, D. Cazalla, L. L. Almstead, J. A. Steitz, and D. DiMaio, “miR-29 and miR-30 regulate B-Myb expression during cellular senescence,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 2, pp. 522–527, 2011. [48] J. J. Zhao, J. Lin, T. Lwin et al., “MicroRNA expression proﬁle and identiﬁcation of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma,” Blood, vol. 115, no. 13, pp. 2630–2639, 2010. [49] M. Fabbri, R. Garzon, A. Cimmino et al., “MicroRNA- 29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 40, pp. 15805–15810, 2007. [50] A. Palamarchuk, A. Efanov, N. Nazaryan et al., “13q14 deletions in CLL involve cooperating tumor suppressors,” Blood, vol. 115, no. 19, pp. 3916–3922, 2010. [51] X. Zhong, N. Li, S. Liang, Q. Huang, G. Coukos, and L. Zhang, “Identiﬁcation of microRNAs regulating reprogram- ming factor LIN28 in embryonic stem cells and cancer cells,” The Journal of Biological Chemistry, vol. 285, no. 53, pp. 41961–41971, 2010. [52] B. S. Marasa, S. Srikantan, J. L. Martindale et al., “MicroRNA proﬁling in human diploid ﬁbroblasts uncovers miR-519 role in replicative senescence,” Aging, vol. 2, no. 6, pp. 333–343, 2010.